Guardant Health Inc.

GH | NASDAQ

Price Alert Chart Builder DCF Calculator

$178.34

+$4.47 (+2.57%)

Sep 22, 2026, 2:43 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ASND Ascendis Pharma A/S	N/A
BBIO BridgeBio Pharma	N/A
EHC Encompass Health	0.63%
ICLR ICON Public Company	N/A
IONS Ionis Pharmaceuticals	N/A
QGEN Qiagen	0.78%
RVTY Revvity	0.19%
SOLV Solventum	N/A
VTRS Viatris	N/A

Dividend Rankings ➞

Recent News

7 days ago / seekingalpha.com
Guardant Health, Inc. (GH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
8 days ago / businesswire.com
Guardant Health's Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening
13 days ago / businesswire.com
Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer
14 days ago / businesswire.com
Business Insider Names Guardant Health One of America's Most Innovative Businesses
29 days ago / gurufocus.com
Guardant Health Inc (GH) Shares Fall 4.4% -- What GF Score of 65 Tells Investors
29 days ago / gurufocus.com
Guardant Health to Appeal Federal District Court Judgment
29 days ago / benzinga.com
Guardant Health Hit With Ongoing Royalties Over Duplex Sequencing Tech
1 month ago / marketbeat.com
Guardant Health Sees Shield, MRD and Oncology Testing Growth Accelerate
1 month ago / seekingalpha.com
Guardant Health, Inc. (GH) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript
1 month ago / fool.com
Executive Dumps Over 14,000 Shares of Biotech Stock, Valued at $2.3 Million